Celltrion Gets Ready For Denosumab Phase III

Study For Prolia Rival Follows Ustekinumab Phase III Trial

Clinical_Trial_Puzzle
Celltrion is getting ready to begin Phase III trials for denosumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products